Management of stable COPD

被引：10

作者：

van der Valk, P

Monninkhof, E

van der Palen, J

Zielhuis, G

van Herwaarden, C

机构：

[1] Medisch Spectrum Twente, Dept Pulm Med, NL-7500 KA Enschede, Netherlands

[2] Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands

[3] Univ Nijmegen, Med Ctr, Dept Pulm Med, Nijmegen, Netherlands

来源：

PATIENT EDUCATION AND COUNSELING | 2004年 / 52卷 / 03期

关键词：

COPD; treatment; exacerbations; health-related quality of life; optimisation of lung function; self-management; self-treatment of exacerbations; smoking cessation;

D O I：

10.1016/S0738-3991(03)00095-8

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Chronic obstructive pulmonary disease (COPD) is a systemic disease with major impact worldwide. In the treatment of COPD a holistic approach should be taken. In order to reach. this, an individual treatment plan should be made which includes at least elements of smoking cessation, optimisation of pulmonary status by pharmacotherapy and exercise embedded in a new lifestyle. Furthermore, more research on nutritional and metabolic intervention strategies for COPD patients is needed. With the availability of all these treatment options, a nihilistic attitude toward the patient with COPD is no longer justified. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：225 / 229

页数：5

共 55 条

[1]

Altose MD, 2000, NEW ENGL J MED, V343, P1902

[2]

*AM THOR SOC, 1991, AM J RESP CRIT CARE, V59, P1666

[3]

[Anonymous], 1980, Ann Intern Med, V93, P391

[4]

[Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1

[5] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].

ANTHONISEN, NR ;

CONNETT, JE ;

KILEY, JP ;

ALTOSE, MD ;

BAILEY, WC ;

BUIST, AS ;

CONWAY, WA ;

ENRIGHT, PL ;

KANNER, RE ;

OHARA, P ;

OWENS, GR ;

SCANLON, PD ;

TASHKIN, DP ;

WISE, RA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505

[6] Medical progress: Chronic obstructive pulmonary disease. [J].

Barnes, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :269-280

[7] New therapies for chronic obstructive pulmonary disease [J].

Barnes, PJ .

THORAX, 1998, 53 (02) :137-147

[8]

Barnes PJ, 2000, AM J RESP CRIT CARE, V161, P342

[9] Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].

Burge, PS ;

Calverley, PMA ;

Jones, PW ;

Spencer, S ;

Anderson, JA ;

Maslen, TK .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303

[10]

Calverley PMA, 2000, AM J RESP CRIT CARE, V161, P341

← 1 2 3 4 5 6 →